Actively Recruiting
Prospective Cohort Study on Thermal Ablation of Malignant Liver Tumors
Led by Leiden University Medical Center · Updated on 2025-09-10
1500
Participants Needed
1
Research Sites
208 weeks
Total Duration
On this page
Sponsors
L
Leiden University Medical Center
Lead Sponsor
P
Philips Healthcare
Collaborating Sponsor
AI-Summary
What this Trial Is About
The endpoint of this study is to develop and validate algorithms, using artificial intelligence and machine learning, to optimize patient selection, treatment planning, treatment evaluation and outcome prediction in patients undergoing thermal ablation of a malignant liver tumor. The long-term objective is to establish thermal ablation as the treatment of choice for the vast majority of patients with a primary or secondary liver tumor by development of an accessible workflow that can be widely implemented in different centers performing thermal ablation. Over a time span of at least four years, data will be collected prospectively, encompassing patient information, tumor characteristics, and treatment details. Additionally, pre-, intra-, and post-procedural imaging will be systematically gathered.
CONDITIONS
Official Title
Prospective Cohort Study on Thermal Ablation of Malignant Liver Tumors
Who Can Participate
Eligibility Criteria
You may qualify if you...
- 18 years or above
- Candidate for percutaneous thermal liver ablation as discussed in a multidisciplinary tumorboard (MDT)
- Informed consent
You will not qualify if you...
- Patients lacking capacity to give informed consent.
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Leiden University Medical Centre
Leiden, Netherlands
Actively Recruiting
Research Team
C
Coosje A. M. Verhagen, Drs.
CONTACT
A
Ariadne L. Velden, van der, Drs.
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here